News
-
-
-
-
PRESS RELEASE
Wildpack Releases Second Quarter Financial Results and Provides Update on the Proposed Debenture Restructuring Transaction, Strategic Alternatives, and Financial Advisor Appointment
Wildpack Beverage Inc. announces Q2 2025 financial results, debenture restructuring progress, strategic alternatives evaluation, and financial advisor engagement -
PRESS RELEASE
Ostrom Climate Reports Fiscal Q2 2025 Financial Statements and Results of Annual General Meeting
Ostrom Climate Solutions Inc. announces Q2 2025 financial results showing revenue growth and cost management. Strategic developments focus on expanding VER unit sales and reducing debt. AGM results include board elections and auditor appointment -
-
-
PRESS RELEASE
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Sanofi's Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia. Novel treatment targets BTK through multi-immune modulation to address root causes of ITP, providing rapid and durable platelet response and improved symptoms -
PRESS RELEASE
Communiqué de presse : Wayrilz de Sanofi est approuvé aux États-Unis comme premier inhibiteur de BTK pour la thrombocytopénie immune
Wayrilz de Sanofi, premier inhibiteur de BTK pour la thrombocytopénie immune, approuvé aux États-Unis par la FDA. Étude LUNA 3 a montré une réponse plaquettaire rapide et durable pour les patients adultes -